These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26080926)

  • 1. Atopic Dermatitis: Drug Delivery Approaches in Disease Management.
    Lalan M; Baweja J; Misra A
    Crit Rev Ther Drug Carrier Syst; 2015; 32(4):323-61. PubMed ID: 26080926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Pharmacotherapeutic Paradigm of Mild to Recalcitrant Atopic Dermatitis.
    Hussain Z; Sahudin S; Thu HE; Shuid AN; Bukhari SN; Kumolosasi E
    Crit Rev Ther Drug Carrier Syst; 2016; 33(3):213-263. PubMed ID: 27910751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Approaches on Novel Topical Delivery Systems for Atopic Dermatitis Treatment.
    Kahraman E; Aydilek N; Güngör S
    Recent Pat Drug Deliv Formul; 2020; 14(3):191-200. PubMed ID: 32819264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug nanocarrier, the future of atopic diseases: Advanced drug delivery systems and smart management of disease.
    Shao M; Hussain Z; Thu HE; Khan S; Katas H; Ahmed TA; Tripathy M; Leng J; Qin HL; Bukhari SNA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():475-491. PubMed ID: 27592075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Atopic Dermatitis.
    Kircik LH
    J Drugs Dermatol; 2019 Feb; 18(2s):s111. PubMed ID: 30811154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone-loaded chitosan nanoparticles.
    Hussain Z; Katas H; Mohd Amin MC; Kumolosasi E; Sahudin S
    Int J Nanomedicine; 2014; 9():5143-56. PubMed ID: 25395851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical therapy in pediatric atopic dermatitis.
    Krakowski AC; Dohil MA
    Semin Cutan Med Surg; 2008 Jun; 27(2):161-7. PubMed ID: 18620139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic management of neurodermatitis atopica].
    Kägi MK
    Ther Umsch; 1998 Aug; 55(8):493-7. PubMed ID: 9757815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of Atopic Dermatitis and Topical Therapies.
    Mayba JN; Gooderham MJ
    J Cutan Med Surg; 2017; 21(3):227-236. PubMed ID: 28300440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapies based on the pathophysiology of atopic dermatitis.
    Bieber T
    J Dtsch Dermatol Ges; 2019 Nov; 17(11):1150-1162. PubMed ID: 31765104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the topical and oral therapy options for treating pediatric atopic dermatitis.
    Glines KR; Stiff KM; Freeze M; Cline A; Strowd LC; Feldman SR
    Expert Opin Pharmacother; 2019 Apr; 20(5):621-629. PubMed ID: 30601075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis.
    Pople PV; Singh KK
    Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is new in atopic dermatitis/eczema?
    Plötz SG; Wiesender M; Todorova A; Ring J
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):441-58. PubMed ID: 25286776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
    Zoller L; Ramon M; Bergman R
    Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus Recommendations on Adjunctive Topical Management of Atopic Dermatitis.
    Del Rosso JQ; Harper J; Kircik L; Albon G; Berson D; Hebert A; Day D
    J Drugs Dermatol; 2018 Oct; 17(10):1070-1076. PubMed ID: 30365587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Nanocarrier-based Approaches to Atopic Dermatitis and Emerging Trends in Drug Development and Design.
    Amisha ; Singh D; Kurmi BD; Singh A
    Curr Drug Deliv; 2024; 21(7):932-960. PubMed ID: 37157192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibodies for Atopic Dermatitis: Progress and Potential.
    Vakharia PP; Silverberg JI
    BioDrugs; 2017 Oct; 31(5):409-422. PubMed ID: 28853008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Atopic Dermatitis-From Standard Pharmacotherapy to Novel Drug Delivery Systems.
    Souto EB; Dias-Ferreira J; Oliveira J; Sanchez-Lopez E; Lopez-Machado A; Espina M; Garcia ML; Souto SB; Martins-Gomes C; Silva AM
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in nanoformulations for atopic dermatitis treatment.
    Ramos Campos EV; Proença PLF; Doretto-Silva L; Andrade-Oliveira V; Fraceto LF; de Araujo DR
    Expert Opin Drug Deliv; 2020 Nov; 17(11):1615-1630. PubMed ID: 32816566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
    Draelos ZD
    Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.